SYN is a Pharmaceutical company based in Athens, focused on medicines- nutritions for chronic, life-threatening and rare diseases, providing one stop shop services for SE European countries for diagnosis, treatment and therapy.
The personnel and the owners have multinational experience and long-term relationships with the health stakeholders and profound capabilities ,with proven efficacy from CxO positions for more than 20 years in SE Europe countries.
Distribution agreement with Fresenius-kabi enteral nutrition
Creation of PharmaVision Europe for expansion in South Balkans
countries (Bulgaria ,Albania ,Kosovo) and Cyprus
Launching Lipiodol orphan liver embolization
relaunching Guerbet’s contrast media portofolio in Greece and Cyprus
Submission cyclotron business plan
Initiation of imaging-diagnosis Unit
Provide patients with high quality, innovative, life changing medicines for diagnosis, treatment and therapy
SYN shall be the preferred partner, well known, respectful and distinct pharmaceutical company proving high quality medications and innovative products
SYN invests in emotional intelligence, promoting teamwork, highly workgroups and a unique altruistic chemistry
SYN embraces innovation, continuous learning and challenging changes
SYN is recognized by everyone as a company that fulfills its responsibilities contributes towards the society
For reporting of any adverse reactions or other matters of Pharmacovigilance please contact 24/7 :